| 名称 | (E/Z)-TG003 |
| 描述 | (E/Z)-TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor. |
| 细胞实验 | 2 × 105 HeLa cells or 1.5 × 105 COS-7 cells resuspended in 2 mL of medium are plated on 6-well dishes, and 2 μL of 10 mM TG003 dissolved in Me2SO (final concentration at 10 μM), or 2 μL of Me2SO, is added to some wells. Cells are trypsinized, and the density is counted every 24 h for 3 days. Cells are then fixed with 1 mL of ice-cold 70% ethanol, washed with PBS, incubated in 1 ml of PBS containing 1 μg/mL DNase-free RNase A and 50 μg/mL propidium iodide for 20 min at 37 °C, and proceeded to cell cycle analysis by FACSCalibur.(Only for Reference) |
| 激酶实验 | In Vitro Kinase Assay : Kinase activity of Clks and SRPKs is assayed in a reaction mixture, containing 200 mM Tris-HCl (pH 7.5), 12.5 mM MgCl2, 8 mM dithiothreitol, 4 mM EGTA, 1–20 μM ATP, 1 μCi of [γ-32P]ATP, 1 μg of synthetic peptide of SF2/ASF RS domain (NH2-RSPSYGRSRSRSRSRSRSRSRSNSRSRSY-OH), and 0.1–1 μg of purified kinases in a final volume of 40 μL. cAMP-dependent protein kinase activity is assayed in a reaction mixture containing 80 mM Tris-HCl (pH 7.5), 12.5 mM MgCl2, 8 mM dithiothreitol, 4 mM EGTA, 10 μM ATP, 1 μCi of [γ-32P]ATP, 5 μg of histone H1, and 1 μg of catalytic subunit of rat cAMP-dependent protein kinase purified. Protein kinase C activity is assayed in a reaction mixture containing 200 mM Tris-HCl (pH 7.5), 12.5 mM MgCl2, 1 mM CaCl2, 80 μg/mL phosphatidylserine, 8 μg/mL diolein, 10 μM ATP, 1 μCi of [γ-32P]ATP, 5 μg of histone H1, and 2 μL of partially purified rat protein kinase C. The final concentration of Me2SO is adjusted to 1% regardless of inhibitor concentration. The reaction mixture is incubated at 30 or 25 °C for mammalian or Xenopus recombinant proteins, respectively, for 10 min, and a half-portion is spotted on P81 phosphocellulose membrane. The kinase assay conditions, including the incubation period and concentration of kinases and substrates, are optimized to maintain the linearity during incubation. The membrane is washed with 5% phosphoric acid solution (SF2/ASF RS domain) or 5% trichloroacetic solution (histone H1) at least over 15 min. The radioactivity is measured using a liquid scintillation counter. The net radioactivity is deduced by subtracting the background count from the reaction mixture without kinase, and the data are expressed as the percentage to the control sample containing the solvent. |
| 体外活性 | 10 μM TG003能够治疗非洲爪蟾体内过度Clk活性诱导的胚胎缺陷. |
| 体内活性 | TG003通过抑制IL-1β异核RNA的剪接阻断血小板产生IL-1β RNA。在3T3-L1脂肪细胞分化过程中,TG003也阻断PKCβII的可变剪接和PPARγ1和PPARγ2的表达。TG003通过抑制Clk1/Sty介导的磷酸化抑制人类β珠蛋白在体外的SF2/ASF依赖性剪接。TG003抑制哺乳动物细胞中Clk1/Sty激酶活性,而对10 μM浓度的HeLa和COS-7细胞的生长没有毒性作用。 |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 6 mg/mL (24.06 mM), Heating is recommended.
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
|
| 关键字 | Wilm's | tumor | TG-003 | TG 003 | splice | site | mutation | mCLK4 | mCLK2 | mCLK1 | Inhibitor | inhibit | Cyclin dependent kinase | CDK | cancer | breast | (E/Z)-TG-003 | (E/Z)-TG003 | (E/Z)TG003 | (E/Z)-TG 003 | (E/Z) TG003 |
| 相关产品 | Seliciclib | Navitoclax | Sodium Oxamate | Abemaciclib methanesulfonate | Palbociclib monohydrochloride | Ribociclib | Abemaciclib | Thymoquinone | CASIN | Venetoclax | (S)-(+)-Ibuprofen | Dinaciclib |
| 相关库 | 抑制剂库 | 抗乳腺癌化合物库 | 抗癌化合物库 | 细胞周期化合物库 | 抗胰腺癌化合物库 | 激酶抑制剂库 | 细胞凋亡化合物库 | 抗衰老化合物库 | NO PAINS 化合物库 | PPI抑制剂库 |